352 related articles for article (PubMed ID: 11979459)
1. Epstein Barr virus associated pediatric nasopharyngeal carcinoma: its correlation with p53 and bcl-2 expression.
Preciado MV; Chabay PA; De Matteo EN; Gismondi MI; Rey G; Zubizarreta P
Med Pediatr Oncol; 2002 May; 38(5):345-8. PubMed ID: 11979459
[TBL] [Abstract][Full Text] [Related]
2. Prognostic significance of the Epstein-Barr virus, p53, Bcl-2, and survivin in nasopharyngeal cancer.
Yip KW; Shi W; Pintilie M; Martin JD; Mocanu JD; Wong D; MacMillan C; Gullane P; O'Sullivan B; Bastianutto C; Liu FF
Clin Cancer Res; 2006 Oct; 12(19):5726-32. PubMed ID: 17020977
[TBL] [Abstract][Full Text] [Related]
3. Epstein-Barr virus (EBV) latent membrane protein 1 induces interleukin-8 through the nuclear factor-kappa B signaling pathway in EBV-infected nasopharyngeal carcinoma cell line.
Ren Q; Sato H; Murono S; Furukawa M; Yoshizaki T
Laryngoscope; 2004 May; 114(5):855-9. PubMed ID: 15126743
[TBL] [Abstract][Full Text] [Related]
4. Expression of Epstein-Barr virus-encoded RNAs as a marker for metastatic undifferentiated nasopharyngeal carcinoma.
Chao TY; Chow KC; Chang JY; Wang CC; Tsao TY; Harn HJ; Chi KH
Cancer; 1996 Jul; 78(1):24-9. PubMed ID: 8646721
[TBL] [Abstract][Full Text] [Related]
5. Epstein-Barr virus LMP1 status in relation to apoptosis, p53 expression and leucocyte infiltration in nasopharyngeal carcinoma.
Shao JY; Ernberg I; Biberfeld P; Heiden T; Zeng YX; Hu LF
Anticancer Res; 2004; 24(4):2309-18. PubMed ID: 15330177
[TBL] [Abstract][Full Text] [Related]
6. Expression of Etk/Bmx tyrosine kinase in the tumorigenicity of nasopharyngeal epithelium and its relation with EB virus infection and the apoptosis-related protein Bcl-2.
Guo L; Guo Y; Xiao S
Cancer Lett; 2006 Feb; 232(2):255-61. PubMed ID: 16458122
[TBL] [Abstract][Full Text] [Related]
7. Cell-cycle regulators, bcl-2 and NF-kappaB in Epstein-Barr virus-positive gastric carcinomas.
Chang MS; Lee HS; Jung EJ; Kim CW; Lee BL; Kim WH
Int J Oncol; 2005 Nov; 27(5):1265-72. PubMed ID: 16211221
[TBL] [Abstract][Full Text] [Related]
8. High frequency of Epstein Barr virus latent membrane protein-1 30 bp deletion in a series of pediatric malignancies in Argentina.
Chabay P; De Matteo E; Merediz A; Preciado MV
Arch Virol; 2004 Aug; 149(8):1515-26. PubMed ID: 15290377
[TBL] [Abstract][Full Text] [Related]
9. [Correlation of Epstein-Barr virus-encoded latent membrane protein 1 (LMP1) to fascin and phosphorylated Stat3 in nasopharyngeal carcinoma].
Liu QY; Han AJ; You SY; Dong Y; Yang QX; Wu JH; Li MF
Ai Zheng; 2008 Oct; 27(10):1070-6. PubMed ID: 18851787
[TBL] [Abstract][Full Text] [Related]
10. Differential expression of Epstein-Barr virus-encoded RNA and several tumor-related genes in various types of nasopharyngeal epithelial lesions and nasopharyngeal carcinoma using tissue microarray analysis.
Fan SQ; Ma J; Zhou J; Xiong W; Xiao BY; Zhang WL; Tan C; Li XL; Shen SR; Zhou M; Zhang QH; Ou YJ; Zhuo HD; Fan S; Zhou YH; Li GY
Hum Pathol; 2006 May; 37(5):593-605. PubMed ID: 16647958
[TBL] [Abstract][Full Text] [Related]
11. Epstein-Barr viral infection in extranodal lymphoma of the head and neck: correlation with prognosis and response to treatment.
Bahnassy AA; Zekri AR; Asaad N; El-Houssini S; Khalid HM; Sedky LM; Mokhtar NM
Histopathology; 2006 Apr; 48(5):516-28. PubMed ID: 16623777
[TBL] [Abstract][Full Text] [Related]
12. Cooperative interactions among p53, bcl-2 and Epstein-Barr virus latent membrane protein 1 in nasopharyngeal carcinoma cells.
Sheu LF; Chen A; Lee HS; Hsu HY; Yu DS
Pathol Int; 2004 Jul; 54(7):475-85. PubMed ID: 15189500
[TBL] [Abstract][Full Text] [Related]
13. Analysis of EBV latency by EBER in situ hybridization in nasopharyngeal carcinoma Spanish patients.
Burgos JS; Vera-Sempere FJ
Anticancer Res; 2001; 21(6A):3921-4. PubMed ID: 11911270
[TBL] [Abstract][Full Text] [Related]
14. [Interaction between Epstein-Barr virus (EBV) gene expression and antibodies to EBV in nasopharyngeal carcinomas].
Furukawa M; Nagayama I; Murono S; Takeshita H; Nishimura T; Yoshizaki T
Rinsho Byori; 1996 Sep; 44(9):832-7. PubMed ID: 8911067
[TBL] [Abstract][Full Text] [Related]
15. Oncogenic role of Epstein-Barr virus-encoded small RNAs (EBERs) in nasopharyngeal carcinoma.
Yoshizaki T; Endo K; Ren Q; Wakisaka N; Murono S; Kondo S; Sato H; Furukawa M
Auris Nasus Larynx; 2007 Mar; 34(1):73-8. PubMed ID: 17129696
[TBL] [Abstract][Full Text] [Related]
16. Expression of Epstein-Barr virus-encoded RNA and biological markers in Italian nasopharingeal carcinomas.
Gabusi E; Lattes C; Fiorentino M; D'Errico A; Grigioni WF
J Exp Clin Cancer Res; 2001 Sep; 20(3):371-6. PubMed ID: 11718217
[TBL] [Abstract][Full Text] [Related]
17. Epstein-Barr virus infection in precursor lesions of nasopharyngeal carcinoma.
Zhong BL; Zong YS; Lin SX; Zhang M; Liang YJ
Ai Zheng; 2006 Feb; 25(2):136-42. PubMed ID: 16480574
[TBL] [Abstract][Full Text] [Related]
18. P53 overexpression and Epstein-Barr virus infection in undifferentiated and squamous cell nasopharyngeal carcinomas.
Niedobitek G; Agathanggelou A; Barber P; Smallman LA; Jones EL; Young LS
J Pathol; 1993 Aug; 170(4):457-61. PubMed ID: 8410495
[TBL] [Abstract][Full Text] [Related]
19. bcl-2 protein is strongly expressed in post-transplant lymphoproliferative disorders.
Chetty R; Biddolph S; Kaklamanis L; Cary N; Stewart S; Giatromanolaki A; Gatter K
J Pathol; 1996 Nov; 180(3):254-8. PubMed ID: 8958801
[TBL] [Abstract][Full Text] [Related]
20. [Bcl-2, p53 expression and Epstein-Barr virus infection in primary nasopharyngeal carcinoma].
Cheng Q; Liu G; Wu Z; Wu Y; Xiao B
Lin Chuang Er Bi Yan Hou Ke Za Zhi; 2001 Oct; 15(10):455-7. PubMed ID: 12541691
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
